BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 21518999)

  • 1. Correlations between MRI white matter lesion location and executive function and episodic memory.
    Smith EE; Salat DH; Jeng J; McCreary CR; Fischl B; Schmahmann JD; Dickerson BC; Viswanathan A; Albert MS; Blacker D; Greenberg SM
    Neurology; 2011 Apr; 76(17):1492-9. PubMed ID: 21518999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional impact of white matter hyperintensities in cognitively normal elderly subjects.
    Murray ME; Senjem ML; Petersen RC; Hollman JH; Preboske GM; Weigand SD; Knopman DS; Ferman TJ; Dickson DW; Jack CR
    Arch Neurol; 2010 Nov; 67(11):1379-85. PubMed ID: 21060015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional white matter hyperintensities in normal aging, single domain amnestic mild cognitive impairment, and mild Alzheimer's disease.
    Kim JH; Hwang KJ; Kim JH; Lee YH; Rhee HY; Park KC
    J Clin Neurosci; 2011 Aug; 18(8):1101-6. PubMed ID: 21723730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coevolution of white matter hyperintensities and cognition in the elderly.
    Maillard P; Carmichael O; Fletcher E; Reed B; Mungas D; DeCarli C
    Neurology; 2012 Jul; 79(5):442-8. PubMed ID: 22815562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of medial temporal atrophy and white matter hyperintensities on the cognitive functions in patients with Alzheimer's disease.
    Shim YS; Youn YC; Na DL; Kim SY; Cheong HK; Moon SY; Park KW; Ku BD; Lee JY; Jeong JH; Kang H; Kim EJ; Lee JS; Go SM; Kim SH; Cha KR; Seo SW
    Eur Neurol; 2011; 66(2):75-82. PubMed ID: 21778730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral white matter hyperintensity in Parkinson's disease: a major risk factor for mild cognitive impairment.
    Kandiah N; Mak E; Ng A; Huang S; Au WL; Sitoh YY; Tan LC
    Parkinsonism Relat Disord; 2013 Jul; 19(7):680-3. PubMed ID: 23623194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of white matter hyperintensity on medial temporal lobe atrophy in Alzheimer's disease.
    Jang JW; Kim S; Na HY; Ahn S; Lee SJ; Kwak KH; Lee MA; Hsiung GY; Choi BS; Youn YC
    Eur Neurol; 2013; 69(4):229-35. PubMed ID: 23344183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different mechanisms of episodic memory failure in mild cognitive impairment.
    Nordahl CW; Ranganath C; Yonelinas AP; DeCarli C; Reed BR; Jagust WJ
    Neuropsychologia; 2005; 43(11):1688-97. PubMed ID: 16009250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Strategically Located White Matter Hyperintensities on Cognition in Memory Clinic Patients with Small Vessel Disease.
    Biesbroek JM; Weaver NA; Hilal S; Kuijf HJ; Ikram MK; Xu X; Tan BY; Venketasubramanian N; Postma A; Biessels GJ; Chen CP
    PLoS One; 2016; 11(11):e0166261. PubMed ID: 27824925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of white matter hyperintensities distribution and clustering on late-life cognitive impairment.
    Jiménez-Balado J; Corlier F; Habeck C; Stern Y; Eich T
    Sci Rep; 2022 Feb; 12(1):1955. PubMed ID: 35121804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
    Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
    J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of white matter hyperintensities and gray matter volume with cognition in older individuals without cognitive impairment.
    Arvanitakis Z; Fleischman DA; Arfanakis K; Leurgans SE; Barnes LL; Bennett DA
    Brain Struct Funct; 2016 May; 221(4):2135-46. PubMed ID: 25833685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategic white matter hyperintensity locations for cognitive impairment: A multicenter lesion-symptom mapping study in 3525 memory clinic patients.
    Coenen M; Kuijf HJ; Huenges Wajer IMC; Duering M; Wolters FJ; Fletcher EF; Maillard PM; ; Barkhof F; Barnes J; Benke T; Boomsma JMF; Chen CPLH; Dal-Bianco P; Dewenter A; Enzinger C; Ewers M; Exalto LG; Franzmeier N; Groeneveld O; Hilal S; Hofer E; Koek DL; Maier AB; McCreary CR; Padilla CS; Papma JM; Paterson RW; Pijnenburg YAL; Rubinski A; Schmidt R; Schott JM; Slattery CF; Smith EE; Steketee RME; Sudre CH; van den Berg E; van der Flier WM; Venketasubramanian N; Vernooij MW; Xin X; DeCarli C; Biessels GJ; Biesbroek JM
    Alzheimers Dement; 2023 Jun; 19(6):2420-2432. PubMed ID: 36504357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. White matter hyperintensities do not impact cognitive function in patients with newly diagnosed Parkinson's disease.
    Dalaker TO; Larsen JP; Dwyer MG; Aarsland D; Beyer MK; Alves G; Bronnick K; Tysnes OB; Zivadinov R
    Neuroimage; 2009 Oct; 47(4):2083-9. PubMed ID: 19539037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of white matter hyperintensity volume progression on rate of cognitive and motor decline.
    Silbert LC; Nelson C; Howieson DB; Moore MM; Kaye JA
    Neurology; 2008 Jul; 71(2):108-13. PubMed ID: 18606964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. White matter lesions impair initiation of FAS flow.
    Fernaeus SE; Almkvist O; Bronge L; Ostberg P; Hellström A; Winblad B; Wahlund LO
    Dement Geriatr Cogn Disord; 2001; 12(1):52-6. PubMed ID: 11125241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Executive function mediates effects of white matter hyperintensities on episodic memory.
    Parks CM; Iosif AM; Farias S; Reed B; Mungas D; DeCarli C
    Neuropsychologia; 2011 Aug; 49(10):2817-24. PubMed ID: 21689669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive and anatomic contributions of metabolic decline in Alzheimer disease and cerebrovascular disease.
    Kuczynski B; Reed B; Mungas D; Weiner M; Chui HC; Jagust W
    Arch Neurol; 2008 May; 65(5):650-5. PubMed ID: 18474742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional quantification of white matter hyperintensity in normal aging, mild cognitive impairment, and Alzheimer's disease.
    Chen YF; Wang H; Chu Y; Huang YC; Su MY
    Dement Geriatr Cogn Disord; 2006; 22(2):177-84. PubMed ID: 16912479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcortical vascular dementia: integrating neuropsychological and neuroradiologic data.
    Price CC; Jefferson AL; Merino JG; Heilman KM; Libon DJ
    Neurology; 2005 Aug; 65(3):376-82. PubMed ID: 16087901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.